0000914190-21-000134.txt : 20210504
0000914190-21-000134.hdr.sgml : 20210504
20210504165422
ACCESSION NUMBER: 0000914190-21-000134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210501
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelderman Kim
CENTRAL INDEX KEY: 0001739054
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 21889458
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-05-01
0000842023
BIO-TECHNE Corp
TECH
0001739054
Kelderman Kim
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
Pres. Diagnostics & Genom
Common Stock
2021-05-01
4
M
0
1667
A
2512
D
Common Stock
2021-05-01
4
F
0
856
427.49
D
1656
D
Restricted Stock Units
2021-05-01
4
M
0
1667
0
D
Common Stock
1667
0
D
Stock Options (Right to Buy)
150.78
2025-05-01
Common Stock
2652
2652
D
Stock Options (Right to Buy)
150.78
2025-05-01
Common Stock
7348
7348
D
Restricted Stock Units
Common Stock
1691
1691
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
12044
12044
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
9033
9033
D
Restricted Stock Units
Common Stock
2363
2363
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
11961
11961
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
15948
15948
D
Restricted Stock Units
Common Stock
2015
2015
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8991
8991
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
11988
11988
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325
8325
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325
8325
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
1,667 restricted stock units vest on 5/1/2021.
Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021
/s/ Brenda S. Furlow as Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
2021-05-04